BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24905340)

  • 1. Ameliorative role of gemfibrozil against partial abdominal aortic constriction-induced cardiac hypertrophy in rats.
    Singh AP; Singh R; Krishan P
    Cardiol Young; 2015 Apr; 25(4):725-30. PubMed ID: 24905340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of obesity on hypertension-induced cardiac remodeling: role of oxidative stress and its modulation by gemfibrozil treatment in rats.
    Singh R; Singh AP; Singh M; Krishan P
    Free Radic Biol Med; 2011 Jan; 50(2):363-70. PubMed ID: 21118715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M; Balakumar P; Singh M
    Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of impact of high fat diet in pathological and physiological left ventricular cardiac hypertrophy by fluvastatin.
    Singh R; Krishan P
    Biomed Pharmacother; 2010 Mar; 64(3):147-53. PubMed ID: 20053524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible role of caspase-3 in pathological and physiological cardiac hypertrophy in rats.
    Balakumar P; Singh M
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):418-24. PubMed ID: 17169122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy.
    Pal Singh A; Kaur T; SinghDahiya R; Singh N; Singh Bedi PM
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):53-9. PubMed ID: 20351560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy.
    Balakumar P; Singh M
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):683-9. PubMed ID: 17235412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium Butyrate Controls Cardiac Hypertrophy in Experimental Models of Rats.
    Patel BM
    Cardiovasc Toxicol; 2018 Feb; 18(1):1-8. PubMed ID: 28389765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats.
    Singh AP; Singh M; Balakumar P
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):596-604. PubMed ID: 18520950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension.
    Siddiq T; Patel VB; Sherwood R; Richardson PJ; Preedy VR
    Exp Mol Pathol; 2001 Feb; 70(1):19-30. PubMed ID: 11170787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy.
    Patel BM; Desai VJ
    Pharmacol Rep; 2014 Apr; 66(2):264-72. PubMed ID: 24911080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of rho-kinase in pathological and physiological cardiac hypertrophy in rats.
    Balakumar P; Singh M
    Pharmacology; 2006; 78(2):91-7. PubMed ID: 16974135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
    Kaur J; Reddy K; Balakumar P
    Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil pretreatment proved protection against acute restraint stress-induced changes in the male rats' hippocampus.
    Khalaj L; Nejad SC; Mohammadi M; Zadeh SS; Pour MH; Ahmadiani A; Khodagholi F; Ashabi G; Alamdary SZ; Samami E
    Brain Res; 2013 Aug; 1527():117-30. PubMed ID: 23850768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Effect of Silymarin in Pressure Overload Induced Experimental Cardiac Hypertrophy.
    Sharma B; Chaube U; Patel BM
    Cardiovasc Toxicol; 2019 Feb; 19(1):23-35. PubMed ID: 29968071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fish oil preserves cardiac function in the hypertrophied rat heart.
    McLennan PL; Abeywardena MY; Dallimore JA; Raederstorff D
    Br J Nutr; 2012 Aug; 108(4):645-54. PubMed ID: 22067847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salutary effects of Corydalis yanhusuo extract on cardiac hypertrophy due to pressure overload in rats.
    Wen C; Wu L; Ling H; Li L
    J Pharm Pharmacol; 2007 Aug; 59(8):1159-65. PubMed ID: 17725860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
    Xu X; Zhang L; Liang J
    Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.